Winter M, Ebner S, Scheuber N, Schulze F, Kinzler M, Walter D
Cancers (Basel). 2025; 17(5).
PMID: 40075667
PMC: 11898960.
DOI: 10.3390/cancers17050820.
He J, Wei C, Huang Y, Xu F, Wang M, Chen Z
Basic Clin Androl. 2025; 35(1):10.
PMID: 40069600
PMC: 11895205.
DOI: 10.1186/s12610-025-00256-3.
Dong K, Gould S, Li M, Sanchez Rivera F
bioRxiv. 2025; .
PMID: 40060429
PMC: 11888284.
DOI: 10.1101/2025.02.23.639784.
Romanova M, Abdikerim S, Dauyey K, Gassanov Z, Baltayev N, Satymbayev S
Genes (Basel). 2025; 16(2).
PMID: 40004500
PMC: 11855340.
DOI: 10.3390/genes16020171.
Popp N, Powell R, Wheelock M, Holmes K, Zapp B, Sheldon K
bioRxiv. 2025; .
PMID: 39975210
PMC: 11838247.
DOI: 10.1101/2024.04.01.587474.
An ontology-based rare disease common data model harmonising international registries, FHIR, and Phenopackets.
Graefe A, Hubner M, Rehburg F, Sander S, Klopfenstein S, Alkarkoukly S
Sci Data. 2025; 12(1):234.
PMID: 39922817
PMC: 11807222.
DOI: 10.1038/s41597-025-04558-z.
The Frequency of c.557A>G in the Dominican Population and Its Association with African Ancestry.
Guevara M, de la Cruz C, Rodrigues-Soares F, Rodriguez E, Manochio C, Penas-Lledo E
Pharmaceutics. 2025; 17(1).
PMID: 39861660
PMC: 11768636.
DOI: 10.3390/pharmaceutics17010008.
Relevance of Next-Generation Sequencing in the Diagnosis of Thalassemia and Hemoglobinopathies: The Experience of Four Italian Diagnostic Hubs.
Selvatici R, Guida V, Maffei M, Irrera M, Margutti A, Bisceglia P
Genes (Basel). 2025; 16(1.
PMID: 39858575
PMC: 11765070.
DOI: 10.3390/genes16010028.
Identification of a novel heterozygous GPD1 missense variant in a Chinese adult patient with recurrent HTG-AP consuming a high-fat diet and heavy smoking.
Li X, Zhang B, Liang X, Han Y, Cheng M, Wei M
BMC Med Genomics. 2025; 18(1):17.
PMID: 39849455
PMC: 11756149.
DOI: 10.1186/s12920-025-02088-6.
BRCA functional domains associated with high risk of multiple primary tumors and domain-related sensitivity to olaparib: the Prometheus Study.
Incorvaia L, Marchetti C, Brando C, Bazan Russo T, Bono M, Perez A
ESMO Open. 2025; 10(2):104076.
PMID: 39847877
PMC: 11795060.
DOI: 10.1016/j.esmoop.2024.104076.
MaveDB 2024: a curated community database with over seven million variant effects from multiplexed functional assays.
Rubin A, Stone J, Bianchi A, Capodanno B, Da E, Dias M
Genome Biol. 2025; 26(1):13.
PMID: 39838450
PMC: 11753097.
DOI: 10.1186/s13059-025-03476-y.
A novel CUL4B gene variant activating Wnt4/β-catenin signal pathway to karyotype 46, XY female with disorders of sex development.
Wang C, Chen H, Chen Q, Qu Y, Yuan K, Liang L
Biol Res. 2025; 58(1):1.
PMID: 39773765
PMC: 11705720.
DOI: 10.1186/s40659-024-00583-1.
Defects in the Mitochondrial Genome of Dogs with Recurrent Tumours.
Kowal K, Ziolkowska-Twarowska K, Tkaczyk-Wlizlo A, Grzybowska-Szatkowska L, Slaska B
Int J Mol Sci. 2025; 25(24.
PMID: 39769179
PMC: 11678272.
DOI: 10.3390/ijms252413414.
Genomic Medicine in the Developing World: Cancer Spectrum, Cumulative Risk and Survival Outcomes for Lynch Syndrome Variant Heterozygotes with Germline Pathogenic Variants in the and Genes.
Ndou L, Chambuso R, Algar U, Boutall A, Goldberg P, Ramesar R
Biomedicines. 2025; 12(12.
PMID: 39767815
PMC: 11672899.
DOI: 10.3390/biomedicines12122906.
Regional Hereditary Cancer Program in Chile: A scalable model of genetic counseling and molecular diagnosis to improve clinical outcomes for patients with hereditary cancer across Latin America.
Landeros N, Vargas-Roig L, Denita S, Mampel A, Hasbun R, Araya H
Biol Res. 2024; 57(1):99.
PMID: 39710803
PMC: 11664851.
DOI: 10.1186/s40659-024-00579-x.
HGVS Nomenclature 2024: improvements to community engagement, usability, and computability.
Hart R, Fokkema I, DiStefano M, Hastings R, Laros J, Taylor R
Genome Med. 2024; 16(1):149.
PMID: 39702242
PMC: 11660784.
DOI: 10.1186/s13073-024-01421-5.
Case report: A novel nonsense mutation in the gene causes nonsyndromic hearing loss in a China family.
Huang C, Huang Z, Wang P, Wu X, Zhou Q, Ding J
Front Genet. 2024; 15:1507600.
PMID: 39698467
PMC: 11652519.
DOI: 10.3389/fgene.2024.1507600.
Two recurrent pathogenic/likely pathogenic variants in PALB2 account for half of PALB2 positive families in Slovenia.
Mesaric V, Blatnik A, Drusany Staric K, Strojnik K, Stegel V, Hotujec S
Hum Genomics. 2024; 18(1):137.
PMID: 39696405
PMC: 11657269.
DOI: 10.1186/s40246-024-00706-5.
Alu-Mediated Duplication and Deletion of Exon 11 Are Frequent Mechanisms of Inactivation, Predisposing Individuals to Hereditary Breast-Ovarian Cancer Syndrome.
Sidoti D, Margotta V, Calosci D, Fiorentini E, Bacci C, Gensini F
Cancers (Basel). 2024; 16(23).
PMID: 39682206
PMC: 11640139.
DOI: 10.3390/cancers16234022.
The impact of RUNX2 gene variants on cleidocranial dysplasia phenotype: a systematic review.
Thaweesapphithak S, Termteerapornpimol K, Wongsirisuwan S, Chantarangsu S, Porntaveetus T
J Transl Med. 2024; 22(1):1099.
PMID: 39627759
PMC: 11613773.
DOI: 10.1186/s12967-024-05904-2.